BAC
Bank of America Corporation
BAC offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
STT
State Street Corporation
STT has a slight edge over BAC overall, supported by stronger modeled upside and lower modeled downside.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
STT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
STT's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like STT.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over STT in the historical PE scenario, which offers more potential upside but is not a forecast.
STT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 10x | $122 | -30% |
| Forward | 12x | $174 | — |
| Fair | 13x | $153 | -12% |
| Current | 14x | $174 | — |
| Expensive | 15x | $183 | +5.6% |
Historical ranges are pointers, not guarantees.
STT's PE is in its expensive range at 14x. If earnings grow as analysts expect, today's price would be 12x next year's earnings, in its fair range.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
STT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for STT, with profitability improving.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC's earnings per share have climbed steadily: $4.19 over the past year, up 14% from the year before, and higher year over year for eight quarters in a row.
STT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $14.95 | +22% |
| Q3 2026 | $12.24 | +30% |
| Q2 2026 | $11.33 | +27% |
| Q1 2026 | $9.85 | +11% |
| Q4 2025 | $9.40 | +14% |
| Q3 2025 | $9.42 | +47% |
| Q2 2025 | $8.90 | +65% |
| Q1 2025 | $8.88 | +64% |
| Q4 2024 | $8.21 | +47% |
STT has the edge over BAC on earnings, with stronger typical year-over-year growth.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over STT on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
STT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $4B | +13% |
| Q2 2026 | $4B | +17% |
| Q1 2026 | $3.8B | +16% |
| Q4 2025 | $3.7B | +7.4% |
| Q3 2025 | $3.5B | +6.1% |
| Q2 2025 | $3.4B | +8.1% |
| Q1 2025 | $3.3B | +4.7% |
| Q4 2024 | $3.4B | +12% |
STT's revenue has grown year over year for 11 quarters in a row: $4B last quarter, up 13% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 35% | +3.6 points |
| Q2 2026 | 34% | +8.5 points |
| Q1 2026 | 26% | +0.5 points |
| Q4 2025 | 25% | -3.1 points |
| Q3 2025 | 31% | +3.4 points |
| Q2 2025 | 26% | -2.8 points |
| Q1 2025 | 25% | +6 points |
| Q4 2024 | 28% | +22 points |
STT has the edge over BAC on profitability, with a higher operating margin.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the edge over STT on cash generation, producing positive trailing cash flow while its opponent burns cash.
STT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.9B | -75% |
| Q2 2026 | -$3B | +$5.8B |
| Q1 2026 | -$12.4B | -672% |
| Q4 2025 | $9.8B | +$17.5B |
| Q3 2025 | $7.7B | +210% |
| Q2 2025 | -$8.8B | -$903M |
| Q1 2025 | $2.2B | +$3.2B |
| Q4 2024 | -$7.7B | -299% |
STT's free cash flow was −$3.7B over the past year, against −$6.6B the year before. Free cash flow isn't a meaningful measure for financial services companies like STT.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over STT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
STT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -1.8M shares |
| 1 year | -3.1% | -8.9M shares |
| 3 years | -12% | -38M shares |
| 5 years | -21% | -74.2M shares |
| Available history | -25% | -94.4M shares |
STT has 279M diluted shares, down 3.1% from a year ago, with $1.6B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $400M |
| Q2 2026 | $400M |
| Q1 2026 | $400M |
| Q4 2025 | $400M |
| Q3 2025 | $400M |
| Q2 2025 | $300M |
| Q1 2025 | $100M |
| Q4 2024 | $550M |
STT spent $1.6B buying back its own shares over the past year, up 19% from the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
STT Net Leverage
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
STT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.5 | Neutral |
| Stochastic | 33.4 | Neutral |
STT's weekly RSI is 54 (neutral) and its Stochastic is 33 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over STT on valuation relative to its sector.
STT PE vs Financial Services Sector
| Metric | STT | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 9% above |
| PE % | 75 | 63 | 12 pts above |
STT is trading at 14x earnings, in line with the Financial Services sector's median of 13x.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
STT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $171.9 | 1.1% above |
| 20 week MA | $180.3 | 3.6% below |
| 50 week MA | $155.2 | 12% above |
| 100 week MA | $129.0 | 35% above |
| 200 week MA | $103.2 | 68% above |
STT has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
STT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $80.1 | $71.8 | -10% |
| 2021 | $71.8 | $93.0 | +30% |
| 2022 | $93.0 | $77.5 | -17% |
| 2023 | $77.5 | $77.5 | 0% |
| 2024 | $77.5 | $98.6 | +27% |
| 2025 | $98.6 | $132.3 | +34% |
| 2026 YTD | $132.3 | $173.7 | +31% |
STT has the edge over BAC on returns for 2026, with the stronger performance.